Related Experiment Videos
Palliative surgery in tetralogy of Fallot
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|September 1, 1981
Summary
The Blalock-Taussig operation is a safe and effective palliative surgery for tetralogy of Fallot in children, offering good long-term results with low mortality. This contrasts with the higher risks associated with the Waterston shunt.
Area of Science:
- Pediatric Cardiac Surgery
- Congenital Heart Disease Management
Background:
- Palliative surgical options for tetralogy of Fallot in young children are debated.
- The Blalock-Taussig operation and Waterston shunt are two palliative procedures.
- Long-term outcomes and safety profiles require further investigation.
Purpose of the Study:
- To review and compare the authors' 13-year experience with the Blalock-Taussig operation and Waterston shunt for tetralogy of Fallot palliation.
- To assess the safety, efficacy, and long-term results of these palliative procedures in pediatric patients.
Main Methods:
- Retrospective review of 195 Blalock-Taussig shunts in 172 patients and 14 Waterston shunts in 14 patients.
- Analysis of patient demographics, procedural complications, mortality rates (early and late), and pulmonary artery growth.
- Comparison of outcomes between the two surgical techniques.
Main Results:
- Blalock-Taussig shunts: 2% early mortality, 2.5% late mortality; no deaths in the last 91 consecutive patients. Pulmonary artery growth was generally good.
- Waterston shunts: 14% operative mortality; reserved for neonates with specific anatomical challenges.
- The Blalock-Taussig operation demonstrated a lower mortality and favorable long-term clinical results compared to the Waterston shunt.
Conclusions:
- The Blalock-Taussig operation is the preferred palliative procedure for tetralogy of Fallot due to its safety and sustained clinical benefits.
- The Waterston shunt carries a high risk and is reserved for select neonates.
- The Blalock-Taussig operation showed improved outcomes and lower mortality than previously reported, with no adverse impact on pulmonary resistance.